drugset

drugset / Trial / NCT04801849

Vitamin E Dosing Study

NCT04801849 ↗

Phase 2 Completed 200 enrolled National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Duke University · collab Indiana University · collab Johns Hopkins Bloomberg School of Public Health · collab Liver Institute Northwest · collab St. Louis University · collab The Cleveland Clinic · collab University of California, San Diego · collab University of California, San Francisco · collab University of Southern California · collab Virginia Commonwealth University · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a multicenter, randomized, double masked, placebo-controlled, parallel treatment groups dosing trial of Vitamin E in adult nonalcoholic fatty liver disease (NAFLD).

Timeline

Start: 2022-08-05
Primary completion: 2025-03-04
Completion: 2025-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Vitamin E	Other / unclassified	200 iu	Oral
Comparator	Vitamin E	Other / unclassified	400 iu	Oral
Comparator	Vitamin E	Other / unclassified	800 iu	Oral

Indications